Cross-ethnic variations in the care of psychiatric patients: A review of contributing factors and practice considerations

Journal of Psychosocial Nursing and Mental Health Services

Volumn 36, Issue 5, 1998, Pages 16-21

  Mohr, Wanda K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; COMMUNICATION DISORDER; CULTURAL ANTHROPOLOGY; DRUG ADMINISTRATION; ETHNOLOGY; HUMAN; MENTAL DISEASE; MENTAL HEALTH SERVICE; METABOLISM; PSYCHIATRIC NURSING; STANDARD; UNITED STATES;

COMMUNICATION BARRIERS; CULTURAL DIVERSITY; DRUG ADMINISTRATION SCHEDULE; HUMANS; MENTAL DISORDERS; MENTAL HEALTH SERVICES; PSYCHIATRIC NURSING; PSYCHOTROPIC DRUGS; UNITED STATES;

EID: 0032067797     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Adebimpe, V.R. (1981). Overview: White norms and psychiatric diagnosis of black patients. The American Journal of Psychiatry, 138, 279-285.
2. Dahl, M.L., Johansson, I., Yue, Q.Y., Sawe, J., Bertilsson, L., IngelmanSundberg, M., & Sjoqvist, F. (1992). Inter-ethnic differences in drug oxidation. Implications for the utilization of anti-depressants and neuroleptics. Clinical Neuropharmacology, 15,(1A), 88A-89A.
3. Dawkins, K. (1996). The interaction of ethnicity, sociocultural factors, and gender in clinical psychopharmacology. Psychopharmacology Bulletin, 32, 283-289.
4. Eastham, J.H., Lacro, J.P., & Jeste, D.V. (1996). Ethnicity and movement disorder. The Mount Sinai Journal of Medicine, 63, 314-319.
5. Edeki, T. (1996). Clinical importance of genetic polymorphism of drug oxidation. The Mount Sinai Journal of Medicine, 63, 291-300.
6. Jeste, D.V., Lindamer, L.A., Evans, J., & Lacro, J.P. (1996). Relationship of ethnicity and gender to schizophrenia and pharmacology of neuroleptics. Psychopharmacology Bulletin, 32, 243-251.
7. Kellner, N.L., & Folks, D.G. (1992). Culture as a variable in drug therapy. Perspectives in Psychiatric Care, 28(1), 33-36.
8. Kroll, J., Linde, P., Habenicht, M., Chan, S., Yang, M., Vang, T., Souvannasoth, L., Nguyen, T., Ly, M., Nguyen, H., & Vang, Y. (1990). Medication compliance, antidepressant blood levels, and side effects in Southeast Asian patients. Journal of Clinical Psychopharmacology, 10, 279-283.
9. Kudzma, E.C. (1992). Drug response: All bodies are not created equal. American Journal of Nursing, 92(12), 48-50.
10. Lawson, W.B. (1996a). The art and science of the psychopharmacotherapy of African Americans. The Mount Sinai Journal of Medicine, 63, 301-305.
11. Lawson, W.B. (1996b). Clinical issues in the pharmacotherapy of African-Americans. Psychopharmacology Bulletin, 32, 275-281.
12. Lessner, I.M., Smith, M.W., Wohl, M., Mena, I., Mehringer, M., & Lin, K.M. (1996). Grain imaging, antidepressants, and ethnicity: Preliminary observations. Psychopharmacology Bulletin, 32, 235-242.
13. Lin, K.M. (1996). Psychopharmacology in cross-cultural psychiatry. The Mount Sinai Journal of Medicine, 63, 283-284.
14. Lin, K.M., Poland, R.E., Wan, Y., Smith, M.W., & Lessner, I.M. (1996). The evolving science of phamlacogenetics: Clinical and ethnic perspectives. Psychopharmacology Bulletin, 32, 205-217.
15. Martinez, R.A. 91996). National Institute of Mental Health: An update on women and minorities in research. The Mount Sinai Journal of Medicine, 63, 332-334.
16. Ramirez, L.F. (1996). Ethnicity and psychopharmacology in Latin America. The Mount Sinai Journal of Medicine, 63, 330-331.
17. Risby, E.D. (1996). Ethnic considerations in the pharmacotherapy of mood disorders. Psychopharmacology Bulletin, 32, 231-234.
18. Ruiz, S., Chu, P., Sramek, J., Rotavu, E., & Herrera, J. (1996). Neuroleptic dosing in Asian and Hispanic outpatients with schizophrenia. The Mount Sinai Journal of Medicine, 63, 306-309.
19. Smith, M.W., & Mendoza, R.P. (1996). Ethnicity and pharmacogenetics. The Mount Sinai Journal of Medicine, 63, 285-290.
20. Sramek, J.J., & Pi, E.H. (1996). Ethnicity and antidepressant response. The Mount Sinai Journal of Medicine, 63, 320-325.
21. Turner, S.M., & Cooley-Quille, M.R. (1996). Socioecological and socioculturel variables in psychopharmacological research: Methodological considerations. Psychopharmacology Bulletin, 32, 183-192.
22. Weerasuriya, K., Jayakody, R.L., Smith, C.A., Wolf, C.R., Tucker, G.T., & Lennard, M.S. (1994). Debrisoquine and mephenenytoin oxidation in Sinhalese: A population study. British Journal of Clinical Pharmacology, 38, 466-470.